Foundayo is Eli Lilly’s daily weight loss pill, known generically as orforglipron. It went on sale in the UK in August 2026 on private prescription at a list price expected to sit between £100 and £120 a month, well below the £330 that Mounjaro now costs at its highest dose. It is licensed for adults with a BMI of 30 or above, or a BMI of 27 and above alongside at least one weight-related condition. It is not yet routinely available on the NHS.
This guide covers what the pill actually is, what it costs, who qualifies, how much weight people lost in trials, and how it stacks up against the two other weight loss drugs most people are already asking about.
What is Foundayo and how does it work?
Foundayo is the brand name for orforglipron, a once-daily tablet made by Eli Lilly. It belongs to the same GLP-1 family as Wegovy and Mounjaro, so it works in a similar way: it mimics a gut hormone that slows how quickly your stomach empties and signals to the brain that you are full. The practical result is that you feel satisfied on less food.
What makes Foundayo different is its chemistry. Wegovy and Mounjaro are peptides, which is why they have to be injected. Orforglipron is a small molecule, so it survives the digestive system and can be taken as a tablet.
That has one everyday advantage worth knowing about. Foundayo can be taken at any time of day, with or without food and with or without water. The oral version of Wegovy, by contrast, has to be taken on an empty stomach with a set amount of water, and you then wait before eating.
The UK timeline
- 1 April 2026 – approved by the US Food and Drug Administration for weight management
- 10 August 2026 – authorised by the UK’s MHRA
- 24 August 2026 – launched in UK pharmacies on private prescription, the first country in Europe to offer it
- Ongoing – NICE appraisal for potential NHS rollout
How much does Foundayo cost in the UK?
Expect roughly £100 to £120 a month for the tablet itself, based on the list price indicated around launch. A few things move that number:
- Dose. Foundayo is stepped up over time, and some pharmacies charge more at higher doses.
- Pharmacy. Online prescribers set their own prices, and consultation or delivery fees may sit on top.
- Ongoing monitoring. Private providers usually build in check-ins at each dose increase.
For context, Lilly’s injectable Mounjaro carries a £330 list price at the highest dose following the 2026 price rise, which makes Foundayo the cheaper of the two Lilly options on paper. That price gap is central to how the drug is being positioned in a market where the UK is more price-sensitive than the US.
Because it is private, the cost is not capped by the NHS and it is not a one-off. Budget for the monthly fee continuing for as long as you stay on treatment, plus the likelihood that stopping leads to some weight returning.
Who can get Foundayo?
The licence follows the pattern set by the injectable drugs:
- BMI of 30 or above, or
- BMI of 27 to 30 with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or sleep apnoea
It is also licensed to improve blood sugar control in adults with poorly controlled type 2 diabetes.
In practice, private prescribers verify your BMI and health history before dispensing, usually with a photo or a video consultation. As with any GLP-1 medicine, it is not intended for use in pregnancy or while breastfeeding, and it is not a substitute for the diet and activity changes that do most of the long-term work.
How much weight do people lose on Foundayo?
In the ATTAIN-1 trial at the highest dose, participants lost an average of about 11% of their body weight over the treatment period. Lilly’s own reporting adds that 59.6% of participants lost at least 10% of their body weight and 39.6% lost at least 15%.
In the ATTAIN-2 trial, which looked at people with type 2 diabetes, average weight loss was around 10.5%.
Worth setting expectations honestly here. The injectable drugs have posted larger average losses in their own trials, and a higher-dose Wegovy has reported figures around 20%. Foundayo’s case is convenience, price and no needles, not maximum possible loss. If your goal is the largest reduction and injections do not bother you, an injectable may still be the stronger clinical choice, and that is a conversation for a prescriber rather than a website.
Foundayo vs Wegovy vs Mounjaro
| Foundayo | Wegovy (pill) | Mounjaro (injection) | |
|---|---|---|---|
| Form | Daily tablet | Daily tablet | Weekly injection |
| Food rules | None, any time of day | Empty stomach, fixed water, wait before eating | None |
| UK price | Around £100 to £120 a month | Set by pharmacy | £330 list price at highest dose |
| Average trial loss | About 11% | Lower at standard dose, higher-dose version reports about 20% | Among the highest of the class |
| NHS | Under NICE review | Restricted specialist access | Restricted specialist access |
If you want the wider picture on how the injectables differ from each other, our comparison of Ozempic, Wegovy and Mounjaro covers dosing, cost and side effects in more detail.
Side effects to expect
The side effects reported in trials were gastrointestinal and mostly mild to moderate: nausea, constipation, diarrhoea, vomiting, indigestion, stomach pain and headache. They tend to be worst in the first weeks and around each dose increase, then settle.
Practical things that help: eat smaller portions more slowly, stop when you feel full rather than at a clean plate, keep water intake up, and prioritise protein so that what you do eat is doing some work. If side effects are severe or you cannot keep fluids down, that is a conversation with your prescriber, not something to push through.
Any suspected side effect can be reported to the MHRA through the Yellow Card scheme.
Can you get Foundayo on the NHS?
Not routinely, and not yet. NICE is still assessing Foundayo, and until that process concludes the drug is private-only for weight management. Even where GLP-1 medicines are available on the NHS, access is usually through specialist weight management services rather than a routine GP prescription, which is the postcode lottery that pharmacy bodies have criticised.
If cost is the blocker, it is worth asking your GP whether you meet the referral criteria for a specialist tier 3 service, since that route is free where it exists.
The counterfeit warning
Pills are easier to fake than injectable pens, and regulators have been explicit about the risk. The MHRA seized £250,000 worth of unlicensed weight loss products from a factory in Northampton last year, and Lilly is pursuing legal action against suppliers it accuses of trading in an illegal market for its drugs.
Buy only from a pharmacy registered with the General Pharmaceutical Council, check the registration number on the GPhC website, and treat any site selling GLP-1 tablets without a consultation as a red flag. A £40 tablet from an unknown seller is not a bargain.
Questions to ask before you start
- Is my BMI and health history properly recorded, or am I self-reporting?
- What happens at each dose increase, and who do I contact if side effects get rough?
- Have my other medicines been reviewed, particularly for diabetes and blood pressure?
- Can I afford this for a year, not a month?
- What is the plan for coming off, and what does maintenance look like?
Frequently asked questions
Is Foundayo available in the UK?
Yes. It was authorised by the MHRA in August 2026 and went on sale on private prescription from 24 August 2026. The UK was the first country in Europe to offer it.
How much does Foundayo cost per month?
Around £100 to £120 a month at list price, depending on the dose and the pharmacy. That is noticeably cheaper than Mounjaro at £330 for the highest dose.
Can you buy Foundayo over the counter?
No. It is a prescription-only medicine, so you need a consultation with a prescriber, usually through a regulated online pharmacy or a private clinic.
Can I get Foundayo on the NHS?
Not routinely. NICE is still appraising it. Some patients may qualify for GLP-1 treatment through specialist weight management services on the NHS, which is a different route.
Is Foundayo better than Mounjaro?
Not in terms of average weight loss, where the injectable drugs have posted stronger trial results. It is better if you want to avoid injections, want no food timing rules, or want a lower monthly cost.
How quickly does Foundayo work?
Appetite changes are usually noticed within the first couple of weeks, but the dose is stepped up gradually over several months and the meaningful weight change accumulates across that period rather than in the first fortnight.
Sources
- Reuters: Eli Lilly launches oral weight-loss drug Foundayo in UK
- The Guardian: New daily diabetes pill that helps with weight loss launches in UK pharmacies
- Eli Lilly: orforglipron weight management results
- NEJM: Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist
This article is for general information and is not medical advice. Foundayo is a prescription medicine, and decisions about starting, changing or stopping treatment should be made with a qualified prescriber. Prices and NHS availability change; figures here reflect reporting from August to November 2026.